U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Method of delivering a therapeutic agent to a target capillary bed

Patent 4345588 Issued on August 24, 1982. Estimated Expiration Date: Icon_subject June 27, 2000. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

3474777

3663687

Method for incorporating substances into protein microspheres
Patent #: 3937668
Issued on: 02/10/1976
Inventor: Zolle

Cancer treatment method
Patent #: 4106488
Issued on: 08/15/1978
Inventor: Gordon

Intracellular temperature measurement
Patent #: 4136683
Issued on: 01/30/1979
Inventor: Gordon

Albumin medicament carrier system
Patent #: 4147767
Issued on: 04/03/1979
Inventor: Yapel, Jr.

Intravascularly-administrable, magnetically-localizable biodegradable carrier
Patent #: 4247406
Issued on: 01/27/1981
Inventor: Widder ,   et al.

Physiological preparation containing loaded cells in suspension and a magnetic agent for local concentration thereof in a living body Patent #: 4269826
Issued on: 05/26/1981
Inventor: Zimmermann ,   et al.

Inventors

Assignee

Application

No. 06/163716 filed on 06/27/1980

US Classes:

600/12, Magnetic element placed within body (e.g., injected, inserted, implanted, etc.)252/62.53, With wax, bitumen, resin, or gum604/308Bandage, pad, shield, or attaching means extendable around body portion

Examiners

Primary: Howell, Kyle L.
Assistant: Swisher, Nancy A. B.

International Classes

A61K 41/00 (20060101)
A61K 9/50 (20060101)
A61K 51/12 (20060101)
G01N 33/543 (20060101)

Abstract

Intravascularly-administrable, magnetically-localizable biodegradable microspheres containing a therapeutic agent, such as an oncolytic agent, are prepared and administered so that they can be permanently localized in a target capillary bed for release of the therapeutic agent therein. The effects of the therapeutic agent can thereby be relatively confined to the area of the capillary bed. Of particular importance is the administration of oncolytic agents by the method, since this permits the undesirable side effects of the oncolytic agents to be substantially reduced, while at the same time increasing the anti-cancer effectiveness of the drug.

Other References

  • Merck Index, entry 202
  • Proceedings Nat'l. Academy of Science, vol. 72, No. 3, pp. 937-940, Mar. 1973, paper by Hahn, Braun et al
  • Freeman et al., J. Appl. Physics., Suppl., vol. 31, No. 5, 4045-4055, (May, 1960)
  • Meyers et al., Amer. J. Roentg., 90, 1068-1077, (Nov. 1963)
  • Takai et al., Chem. Abs., vol. 80, No. 5, p. 293, Abstract 52392a, (1974)
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?